Fingerprint
Dive into the research topics of 'Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen, Syed Mahmood Shah, Jeffery S. Heier, Diana V. Do, Jennifer Lim, David Boyer, Prema Abraham, Peter A. Campochiaro
Research output: Contribution to journal › Article › peer-review
284
Scopus
citations